<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "1: Risk Factors ", fill: "#701c1c"},
{source: "1: Risk Factors ", target: "1: December ", fill: "#701c1c"},
{source: "1: December ", target: "1: could incur net losses", fill: "#701c1c"},
{source: "1: Risk Factors ", target: "6: significant", fill: "#b7410e"},
{source: "6: significant", target: "6: profitability", fill: "#b7410e"},
{source: "6: profitability", target: "6: debt could", fill: "#b7410e"},
{source: "6: debt could", target: "6: negatively impacted by", fill: "#b7410e"},
{source: "6: negatively impacted by", target: "6: generate sales growth", fill: "#b7410e"},
{source: "6: significant", target: "9: government", fill: "#a9a9a9"},
{source: "9: government", target: "9: reimbursement", fill: "#a9a9a9"},
{source: "9: reimbursement", target: "9: adversely", fill: "#a9a9a9"},
{source: "9: adversely", target: "9: profitability", fill: "#a9a9a9"},
{source: "9: government", target: "35: income from operations percentage", fill: "#d8bfd8"},
{source: "35: income from operations percentage", target: "35: operations", fill: "#d8bfd8"},
{source: "35: operations", target: "35: based on", fill: "#d8bfd8"},
{source: "35: based on", target: "35: adjustments", fill: "#d8bfd8"},
{source: "35: adjustments", target: "35: inventory during interim periods following", fill: "#d8bfd8"},
{source: "35: inventory during interim periods following", target: "35: physical inventory could adversely affect", fill: "#d8bfd8"},
{source: "35: physical inventory could adversely affect", target: "35: financial condition", fill: "#d8bfd8"},
{source: "35: income from operations percentage", target: "36: services provided at", fill: "#fefe33"},
{source: "36: services provided at", target: "36: patientcare centers", fill: "#fefe33"},
{source: "36: patientcare centers", target: "36: may negatively impact", fill: "#fefe33"},
{source: "36: services provided at", target: "START_HERE", fill: "#fefe33"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Consult</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Promise policy support</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Complain</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December">December</a></td>
      <td>December is the twelfth and the final month of the year in the Julian and Gregorian calendars. It is also the last of seven months to have a length of 31 days.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_17">December 17</a></td>
      <td>December 17 is the 351st day of the year (352nd in leap years) in the Gregorian calendar;  14 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n497 BC – The first Saturnalia festival was celebrated in ancient Rome.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_10">December 10</a></td>
      <td>December 10 is the 344th day of the year (345th in leap years) in the Gregorian calendar;  21 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n1317 – The "Nyköping Banquet": King Birger of Sweden treacherously seizes his two brothers Valdemar, Duke of Finland and Eric, Duke of Södermanland, who were subsequently starved to death in the dungeon of Nyköping Castle.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_1">December 1</a></td>
      <td>December is the twelfth and the final month of the year in the Julian and Gregorian calendars. It is also the last of seven months to have a length of 31 days.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/2016_in_aviation">2016 in aviation</a></td>
      <td>This is a list of aviation-related events from 2016.\n\n\n== Events ==\n\n\n=== January ===\nThe Government of Italy permitted United States unmanned aerial vehicles (UAVs or drones) to fly strike missions from Naval Air Station Sigonella in Sicily where the US has operated unarmed surveillance UAVs since 2001 against Islamic State targets in Libya, but only if they are "defensive," protecting U.S. forces or rescuers retrieving downed pilots.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_18">December 18</a></td>
      <td>December 11 is the 345th day of the year (346th in leap years) in the Gregorian calendar;  20 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n220 – Emperor Xian of Han is forced to abdicate the throne by Cao Cao's son Cao Pi, ending the Han dynasty.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_8">December 8</a></td>
      <td>December 3 is the 337th day of the year (338th in leap years) in the Gregorian calendar;  28 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n915 – Pope John X crowns Berengar I of Italy as Holy Roman Emperor (probable date).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_figures">Significant figures</a></td>
      <td>Significant figures (also known as the significant digits, precision or resolution) of a number in positional notation are digits in the number that are reliable and necessary to indicate the quantity of something.\nIf a number expressing the result of a measurement (e.g., length, pressure, volume, or mass) has more digits than the number of digits allowed by the measurement resolution, then only as many digits as allowed by the measurement resolution are reliable, and so only these can be significant figures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bit_numbering">Bit numbering</a></td>
      <td>In computing, bit numbering is the convention used to identify the bit positions in a binary number.\n\n\n== Bit significance and indexing ==\n\nIn computing, the least significant bit (LSB) is the bit position in a binary integer representing the binary 1s place of the integer.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Statistical_significance">Statistical significance</a></td>
      <td>In statistical hypothesis testing, a result has statistical significance when it is very unlikely to have occurred given the null hypothesis. More precisely, a study's defined significance level, denoted by \n  \n    \n      \n        α\n      \n    \n    {\displaystyle \alpha }\n  , is the probability of the study rejecting the null hypothesis, given that the null hypothesis is true; and the p-value of a result, \n  \n    \n      \n        p\n      \n    \n    {\displaystyle p}\n  , is the probability of obtaining a result at least as extreme, given that the null hypothesis is true.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Others">Significant Others</a></td>
      <td>The term significant other (SO) has different uses in psychology and in colloquial language. Colloquially "significant other" is used as a gender-neutral term for a person's partner in an intimate relationship without disclosing or presuming anything about marital status, relationship status, gender identity, or sexual orientation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Simpsons">The Simpsons</a></td>
      <td>The Simpsons is an American animated sitcom created by Matt Groening for the Fox Broadcasting Company. The series is a satirical depiction of American life, epitomized by the Simpson family, which consists of Homer, Marge, Bart, Lisa, and Maggie.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_Mother">Significant Mother</a></td>
      <td>Significant Mother is an American television sitcom created by Erin Cardillo and Richard Keith. Starring Josh Zuckerman, Nathaniel Buzolic and Krista Allen, it premiered on The CW network on August 3 and ended its run on October 5, 2015.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Capitation_(healthcare)">Capitation (healthcare)</a></td>
      <td>Capitation is a payment arrangement for health care service providers. It pays a set amount for each enrolled person assigned to them, per period of time, whether or not that person seeks care.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Diagnosis-related_group">Diagnosis-related group</a></td>
      <td>Diagnosis-related group (DRG) is a system to classify hospital cases into one of originally 467 groups, with the last group (coded as 470 through v24, 999 thereafter) being "Ungroupable". This system of classification was developed as a collaborative project by Robert B Fetter, PhD, of the Yale School of Management, and John D. Thompson, MPH, of the Yale School of Public Health.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse">Adverse</a></td>
      <td>Adverse or adverse interest, in law, is anything that functions contrary to a party's interest. This word should not be confused with averse.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse_party">Adverse party</a></td>
      <td>An adverse party is an opposing party in a lawsuit under an adversary system of law.  In general, an adverse party is a party against whom judgment is sought or "a party interested in sustaining a judgment or decree." For example, the adverse party for a defendant is the plaintiff.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse_(film)">Adverse (film)</a></td>
      <td>Adverse is a 2020 American crime thriller film written and directed by Brian Metcalf and starring Thomas Nicholas, Lou Diamond Phillips, Sean Astin, Kelly Arjen, Penelope Ann Miller, and Mickey Rourke. It premiered at the Fantasporto Film Festival, Portugal's largest film festival, on February 28, 2020.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Anthony_Adverse">Anthony Adverse</a></td>
      <td>Anthony Adverse is a 1936 American epic historical drama film directed by Mervyn LeRoy and starring Fredric March and Olivia de Havilland. The screenplay by Sheridan Gibney draws elements of its plot from eight of the nine books in Hervey Allen's historical novel, Anthony Adverse.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Hostile_witness">Hostile witness</a></td>
      <td>A hostile witness, also known as an adverse witness or an unfavorable witness, is a witness at trial whose  testimony on direct examination is either openly antagonistic or appears to be contrary to the legal position of the party who called the witness. This concept is used in the legal proceedings in the United States, and analogues of it exist in other legal systems in Western countries.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Adverse_event">Adverse event</a></td>
      <td>An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product.AEs in patients participating in clinical trials must be reported to the study sponsor and if required could be reported to local ethics committee.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Diuretic">Diuretic</a></td>
      <td>Diuresis () is increased urination (polyuria) or, in the related word senses more often intended, the physiologic process that produces such an increase or the administration of medications to encourage that process. It involves extra urine production in the kidneys as part of the body's homeostatic maintenance of fluid balance.In healthy people, the drinking of extra water produces mild diuresis to maintain the body water  balance.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Arithmetic">Arithmetic</a></td>
      <td>Arithmetic (from Ancient Greek  ἀριθμός (arithmós) 'number', and  τική [τέχνη] (tikḗ [tékhnē]) 'art, craft') is an elementary part of mathematics that consists of the study of the properties of the traditional operations on numbers—addition, subtraction, multiplication, division, exponentiation, and extraction of roots. In the 19th century, Italian mathematician Giuseppe Peano formalized arithmetic with his Peano axioms, which are highly important to the field of mathematical logic today.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Bitwise_operation">Bitwise operation</a></td>
      <td>In computer programming, a bitwise operation operates on a bit string, a bit array or a binary numeral (considered as a bit string) at the level of its individual bits. It is a fast and simple action, basic to the higher-level arithmetic operations and directly supported by the processor.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_management">Operations management</a></td>
      <td>Operations management is an area of management concerned with designing and controlling the process of production and redesigning business operations in the production of goods or services. It involves the responsibility of ensuring that business operations are efficient in terms of using as few resources as needed and effective in meeting customer requirements.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_operations_center">Emergency operations center</a></td>
      <td>An emergency operations center (EOC) is a central command and control facility responsible for carrying out the principles of emergency preparedness and emergency management, or disaster management functions at a strategic level during an emergency, and ensuring the continuity of operation of a company, political subdivision or other organization.\nAn EOC is responsible for strategic direction and operational decisions and does not normally directly control field assets, instead leaving tactical decisions to lower commands.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Surgery">Surgery</a></td>
      <td>Surgery is a medical or dental specialty that uses operative manual and instrumental techniques on a person to investigate or treat a pathological condition such as a disease or injury, to help improve bodily function, appearance, or to repair unwanted ruptured areas.\nThe act of performing surgery may be called a surgical procedure, operation, or simply "surgery".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Special_operations">Special operations</a></td>
      <td>Special operations (S.O.) are military activities conducted, according to NATO, by "specially designated, organized, selected, trained, and equipped forces using unconventional techniques and modes of employment". Special operations may include reconnaissance, unconventional warfare, and counter-terrorism actions, and are typically conducted by small groups of highly-trained personnel, emphasizing sufficiency, stealth, speed, and tactical coordination, commonly known as "special forces".</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Meharry_Medical_College_School_of_Dentistry">Meharry Medical College School of Dentistry</a></td>
      <td>The School of Dentistry is a dental school within Meharry Medical College located in the United States city of Nashville. The school is one of the dental schools in the state of Tennessee.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/European_Union_of_Medical_Specialists">European Union of Medical Specialists</a></td>
      <td>The European Union of Medical Specialists (UEMS: Union Européenne des Médecins Spécialistes) is a professional organisation of doctors representing medical specialists in the European Union, which was founded in 1958. It is the oldest medical organization in Europe, and represents about 1.6 million medical specialists..</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Emergency_medicine">Emergency medicine</a></td>
      <td>Emergency medicine is the medical speciality concerned with the care of illnesses or injuries requiring immediate medical attention. Emergency physicians (often called “ER doctors” in the United States) continuously learn to care for unscheduled and undifferentiated patients of all ages.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Milton_R._Wolf">Milton R. Wolf</a></td>
      <td>Milton R. Wolf (born April 8, 1971) is an American physician. He is a Tea Party movement-aligned activist who ran against incumbent Kansas U.S. Senator Pat Roberts for the Republican Party nomination in the 2014 United States Senate election.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/LGBT_healthcare_in_the_United_States_Veterans_Health_Administration">LGBT healthcare in the United States Veterans Health Administration</a></td>
      <td>The United States Veterans Health Administration (VHA) has a lesbian, gay, bisexual and transgender (LGBT) Program through the Office of Patient Care Services. However, VHA does not currently collect data on veteran’s sexual orientation or gender identity.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>HANGER ORTHOPEDIC GROUP INC      Item 1A <font color="blue">Risk Factors </font>19  ITEM 1A  RISK FACTORS       We incurred net losses for the years ended <font color="blue">December </font>31, 2004 and 2001 and     <font color="blue">could <font color="blue">incur net losses</font></font> in the future</td>
    </tr>
    <tr>
      <td>We incurred a net loss of dlra23dtta4 million for the year ended <font color="blue">December </font>31, 2004     primarily  as a result of the <font color="blue">recognition</font> of dlra45dtta8 million in non-cash     charges related to <font color="blue">goodwill impairment</font></td>
    </tr>
    <tr>
      <td>For the years ended <font color="blue">December </font>31,     2005, 2003 and 2002, however, we <font color="blue">generated net income</font> of dlra17dtta8 million,     dlra15dtta6 million and dlra23dtta0 million, respectively</td>
    </tr>
    <tr>
      <td>Following the NovaCare O&amp;P     <font color="blue">acquisition</font>, we incurred a net loss of dlra9dtta7 million for the year ended     <font color="blue">December </font>31, 2001</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> that we will not <font color="blue">incur net losses</font> in the     future</td>
    </tr>
    <tr>
      <td>We  are  highly  leveraged and have <font color="blue">significant</font> fixed operating costs;     therefore  our  <font color="blue">profitability</font> and ability to service our <font color="blue">debt could</font> be     <font color="blue"><font color="blue">negatively</font> impacted by</font> our ability to <font color="blue">generate sales growth</font></td>
    </tr>
    <tr>
      <td>We  are <font color="blue">highly leveraged</font> and have a <font color="blue">significant</font> amount of fixed costs</td>
    </tr>
    <tr>
      <td>Therefore, our ability to continue to service our debt and <font color="blue">fund necessary</font>     <font color="blue">capital additions</font> is <font color="blue"><font color="blue">dependent</font> on</font> our ability to grow sales and control     <font color="blue">inflationary increases</font> in our fixed costs</td>
    </tr>
    <tr>
      <td>Changes in <font color="blue">government</font> <font color="blue">reimbursement</font> levels could <font color="blue">adversely</font> affect our net     sales, cash flows and <font color="blue">profitability</font></td>
    </tr>
    <tr>
      <td>We derived 41dtta2prca, 44dtta3prca and 44dtta8prca of our net sales for the years ended     <font color="blue">December </font>31, 2005, 2004 and 2003, respectively, from <font color="blue">reimbursement</font>s for O&amp;P     services and <font color="blue">products from programs administered by</font> Medicare, Medicaid and     the  <font color="blue">US Veterans Administration</font></td>
    </tr>
    <tr>
      <td>Each of these programs sets maximum     <font color="blue">reimbursement</font> levels for O&amp;P services and products</td>
    </tr>
    <tr>
      <td>If these <font color="blue">agencies reduce</font>     <font color="blue">reimbursement</font> levels for O&amp;P services and products in the future, our net     <font color="blue">sales could substantially decline</font></td>
    </tr>
    <tr>
      <td>In addition, the percentage of our net     <font color="blue">sales derived from</font> these <font color="blue">sources may increase as</font> the portion of the US     population over age 65 continues to grow, making us more vulnerable to     maximum <font color="blue">reimbursement</font> level reductions by these <font color="blue">organizations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Reduced     </font><font color="blue">government</font>  <font color="blue">reimbursement</font> levels could result in <font color="blue">reduced private payor</font>     <font color="blue">reimbursement</font> levels because <font color="blue">fee schedules</font> of certain third-party payors are     indexed to Medicare</td>
    </tr>
    <tr>
      <td>Furthermore, the healthcare industry is experiencing a     trend towards cost <font color="blue">containment</font> as <font color="blue">government</font> and other third-party payors     seek to impose lower <font color="blue">reimbursement</font> rates and <font color="blue">negotiate reduced contract</font>     <font color="blue">rates with service providers</font></td>
    </tr>
    <tr>
      <td>This trend could <font color="blue">adversely</font> affect our net     sales</td>
    </tr>
    <tr>
      <td>Medicare provides for <font color="blue">reimbursement</font> for O&amp;P products and services     <font color="blue"><font color="blue">based on</font> prices set forth</font> in <font color="blue">fee schedules</font> for <font color="blue">ten regional service areas</font></td>
    </tr>
    <tr>
      <td>Additionally, if the US Congress were to <font color="blue">legislate <font color="blue">modifications</font></font> to the     Medicare <font color="blue">fee schedules</font>, our <font color="blue">net sales from</font> Medicare and other <font color="blue">payors could</font>     be <font color="blue">adversely</font> and <font color="blue">materially affected</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot predict whether</font> any such     <font color="blue">modifications</font> to the <font color="blue">fee schedules</font> will be enacted or what the final form of     any  <font color="blue">modifications</font>  might  be</td>
    </tr>
    <tr>
      <td>See previous discussion in Item 1 under     “Reimbursement” and “Government Regulation</td>
    </tr>
    <tr>
      <td>” <font color="blue">In November </font>2003, <font color="blue">Congress     </font>legislated a three-year freeze on Medicare <font color="blue">reimbursement</font> levels beginning     January 1, 2004 on all O&amp;P services</td>
    </tr>
    <tr>
      <td>The effect of this <font color="blue">legislation</font> has been     a  downward  <font color="blue">pressure on</font> our <font color="blue">income from <font color="blue">operations</font></font></td>
    </tr>
    <tr>
      <td>We have, however,     <font color="blue">initiated certain purchasing</font> and <font color="blue">efficiency programs which</font> we believe will     <font color="blue">minimize such effects</font></td>
    </tr>
    <tr>
      <td>19       _________________________________________________________________       <font color="blue">Changes  </font>in payor <font color="blue">reimbursement</font>s could <font color="blue">negatively</font> affect our net sales     volume</td>
    </tr>
    <tr>
      <td>Recent years have seen a <font color="blue">consolidation</font> of <font color="blue">healthcare companies coupled with</font>     certain  payors  <font color="blue">terminating</font>  contracts,  imposing  caps  or  reducing     <font color="blue">reimbursement</font> for O&amp;P products</td>
    </tr>
    <tr>
      <td>Additionally, employers are <font color="blue">increasingly</font>     <font color="blue">pushing healthcare costs down</font> to their employees</td>
    </tr>
    <tr>
      <td>These <font color="blue">trends could</font> result     in decreased O&amp;P revenue</td>
    </tr>
    <tr>
      <td>If we <font color="blue">cannot collect</font> our <font color="blue"><font color="blue">accounts</font> receivable</font> and <font color="blue">effectively manage</font> our     inventory, our business, results of <font color="blue">operations</font>, <font color="blue">financial condition</font> and     ability to satisfy our <font color="blue">obligations under</font> our <font color="blue"><font color="blue">indebtedness</font> could</font> be <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>As of <font color="blue">December </font>31, 2005 and 2004, our <font color="blue"><font color="blue">accounts</font> receivable</font> over 120 days     represented approximately 20dtta4prca and 23dtta8prca of total <font color="blue"><font color="blue">accounts</font> receivable</font>     outstanding in each period, respectively</td>
    </tr>
    <tr>
      <td>If we <font color="blue">cannot collect</font> our <font color="blue">accounts</font>     receivable, our business, results of <font color="blue">operations</font>, <font color="blue">financial condition</font> and     ability to satisfy our <font color="blue">obligations under</font> our <font color="blue"><font color="blue">indebtedness</font> could</font> be <font color="blue">adversely</font>     affected</td>
    </tr>
    <tr>
      <td>In addition, our principal means of <font color="blue">control with respect</font> to     <font color="blue">accounting</font> for inventory and costs of goods sold is a <font color="blue">physical inventory</font>     <font color="blue">conducted on</font> an <font color="blue">annual basis</font></td>
    </tr>
    <tr>
      <td>This <font color="blue">accepted method</font> of <font color="blue">accounting</font> controls     and <font color="blue">procedures may</font> result in an <font color="blue">understatement</font> or overstatement, as the case     may be, of <font color="blue">inventory between</font> our <font color="blue">annual physical inventories</font></td>
    </tr>
    <tr>
      <td>In <font color="blue">conjunction with</font> our <font color="blue">physical inventory</font> performed     on  October 1, 2004, we recorded a dlra1dtta6 million increase in inventory</td>
    </tr>
    <tr>
      <td>Because our <font color="blue">income from <font color="blue">operations</font></font> percentage is <font color="blue">based on</font> our inventory     levels,  <font color="blue">adjustments</font> to <font color="blue">inventory during interim periods following</font> our     <font color="blue">physical inventory</font> could <font color="blue">adversely</font> affect our results of <font color="blue">operations</font> and     <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>A decrease in the quality of <font color="blue">services provided at</font> our patient-care centers     may <font color="blue">negatively</font> impact our reputation</td>
    </tr>
    <tr>
      <td><font color="blue">Maintaining </font>our market share is <font color="blue"><font color="blue">dependent</font> on</font> us providing quality services     and products</td>
    </tr>
    <tr>
      <td>Increasingly, payors are <font color="blue">seeking out service providers</font> that     control a <font color="blue">significant</font> market presence and <font color="blue"><font color="blue">abide by</font> high quality standards</font></td>
    </tr>
    <tr>
      <td>In  addition,  suppliers  attempting to <font color="blue">sell directly</font> to hospitals and     healthcare  <font color="blue">management</font>  companies,  O&amp;P  <font color="blue">competitors</font> and other service     providers,  <font color="blue">such as physical therapists</font>, are <font color="blue">continually attempting</font> to     penetrate the market</td>
    </tr>
    <tr>
      <td>If we are unable to <font color="blue">abide by</font> our standard operating     procedures and <font color="blue">continue providing quality services</font> to our patients, our net     sales and <font color="blue">market presence could</font> be <font color="blue">adversely</font> impacted</td>
    </tr>
    <tr>
      <td>20       _________________________________________________________________       If we are unable to maintain good <font color="blue">relations with</font> our suppliers, our existing     <font color="blue">purchasing discounts may</font> be jeopardized, <font color="blue">which could</font> <font color="blue">adversely</font> affect our     gross margins</td>
    </tr>
    <tr>
      <td>We  currently  enjoy <font color="blue">significant</font> purchasing discounts with most of our     suppliers, and our ability to sustain our <font color="blue">income from <font color="blue">operations</font></font> has been,     and <font color="blue">will continue</font> to be, <font color="blue">dependent</font>, in part, on our ability to continue to     obtain favorable <font color="blue">discount terms from</font> our suppliers</td>
    </tr>
    <tr>
      <td>These terms may be     subject to changes in suppliers’ strategies from time to time, <font color="blue">which could</font>     <font color="blue">adversely</font> affect our gross <font color="blue">margins over</font> time</td>
    </tr>
    <tr>
      <td>The <font color="blue">profitability</font> of our     business depends, in part, upon our ability to maintain good <font color="blue">relations with</font>     these suppliers</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> the <font color="blue">continued employment</font> of our <font color="blue">orthotists</font> and <font color="blue">prosthetists</font> who     work at our patient-care centers and their <font color="blue"><font color="blue">relationships</font> with physicians</font> and     patients</td>
    </tr>
    <tr>
      <td>Our ability to provide O&amp;P <font color="blue">services at</font> our patient-care centers     would be impaired and our <font color="blue">net sales reduced</font> if we were unable to maintain     these <font color="blue">relationships</font></td>
    </tr>
    <tr>
      <td>Our <font color="blue">net sales would</font> be reduced if a <font color="blue">significant</font> number of our <font color="blue">practitioners</font>     leave us</td>
    </tr>
    <tr>
      <td>In addition, any failure of our <font color="blue">practitioners</font> to maintain the     quality of <font color="blue">care provided</font> or to <font color="blue">otherwise adhere</font> to <font color="blue">certain general</font> operating     procedures  at  our  <font color="blue">facilities</font>  or  any damage to the reputation of a     <font color="blue">significant</font>  number  of  our  <font color="blue">practitioners</font> could <font color="blue">adversely</font> affect our     reputation, subject us to <font color="blue">liability</font> and <font color="blue">significant</font>ly reduce our net sales</td>
    </tr>
    <tr>
      <td>A substantial amount of our business is <font color="blue">derived from orthopedic surgeons</font> and     other <font color="blue">healthcare providers</font></td>
    </tr>
    <tr>
      <td>If the quality of our services and products     declines in the opinion of these <font color="blue">healthcare providers</font>, they may cease to     recommend our products, which would <font color="blue">adversely</font> affect our net sales</td>
    </tr>
    <tr>
      <td>If the non-<font color="blue">competition</font> <font color="blue">agreements</font> we have with our key <font color="blue">executive officers</font>     and key <font color="blue">practitioners</font> were found by a court to be unenforceable, we could     experience increased <font color="blue">competition</font> resulting in a decrease in our net sales</td>
    </tr>
    <tr>
      <td>We generally enter into employment <font color="blue">agreements</font> with our <font color="blue">executive officers</font>     and a <font color="blue">significant</font> number of our <font color="blue">practitioners</font> which contain non-compete and     other  provisions</td>
    </tr>
    <tr>
      <td>The  laws  of  each  state  differ  <font color="blue">concerning</font> the     <font color="blue">enforceability</font> of non-<font color="blue">competition</font> <font color="blue">agreements</font></td>
    </tr>
    <tr>
      <td>State <font color="blue">courts will</font> examine all     of  the facts and <font color="blue">circumstances at</font> the time a <font color="blue">party seeks</font> to enforce a     non-compete covenant</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot predict with certainty whether</font> or not a     <font color="blue">court will enforce</font> a non-compete covenant in any given situation <font color="blue">based on</font>     the  facts and <font color="blue">circumstances at</font> that time</td>
    </tr>
    <tr>
      <td>If one of our <font color="blue">key executive</font>     officers and/or a <font color="blue">significant</font> number of our <font color="blue">practitioners</font> were to leave us     and the <font color="blue">courts refused</font> to enforce the non-compete covenant, we might be     subject to increased <font color="blue">competition</font>, <font color="blue">which could</font> materially and <font color="blue">adversely</font>     affect our business, <font color="blue">financial condition</font> and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We face periodic reviews, audits and <font color="blue"><font color="blue">investigations</font> under</font> our <font color="blue">contracts with</font>     federal and state <font color="blue">government</font> agencies, and these <font color="blue">audits could</font> have adverse     findings that may <font color="blue">negatively</font> impact our business</td>
    </tr>
    <tr>
      <td>We <font color="blue">contract with various federal</font> and state <font color="blue">government</font>al agencies to provide     O&amp;P  services</td>
    </tr>
    <tr>
      <td>Pursuant to these contracts, we are subject to various     <font color="blue">government</font>al reviews, audits and <font color="blue">investigations</font> to verify our compliance     with the contracts and applicable laws and <font color="blue">regulations</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">adverse review</font>,     audit or investigation could result in:                                         21       _________________________________________________________________         • refunding of amounts we have <font color="blue">been paid pursuant</font> to our <font color="blue">government</font>     contracts;         • imposition of fines, penalties and other <font color="blue">sanctions on us</font>;         • loss of our right to <font color="blue">participate</font> in <font color="blue">various federal programs</font>;         • damage to our reputation in <font color="blue">various markets</font>; or         • material and/or adverse effects on our business, <font color="blue">financial condition</font> and     results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>We  are  subject  to  numerous  federal,  state and local <font color="blue">government</font>al     <font color="blue">regulations</font>, noncompliance with <font color="blue">which could</font> result in <font color="blue">significant</font> penalties     that could have a material adverse effect on our business</td>
    </tr>
    <tr>
      <td>A <font color="blue">failure by us</font> to <font color="blue">comply with</font> the <font color="blue">numerous federal</font>, state and/or local     healthcare and other <font color="blue">government</font>al <font color="blue">regulations</font> to which we are subject,     including the <font color="blue">regulations</font> discussed under “Government Regulation” in Item 1     above, could result in <font color="blue">significant</font> penalties and adverse consequences,     including <font color="blue">exclusion from</font> the <font color="blue">Medicare and Medicaid </font>programs, <font color="blue">which could</font>     have a material adverse effect on our business</td>
    </tr>
    <tr>
      <td>If the results of the current <font color="blue">investigations</font> over the <font color="blue">billing allegations at</font>     the West Hempstead patient-care center and the associated class action     lawsuits are not resolved in our favor or if <font color="blue">such allegations</font> are expanded     to  other  patient-care centers and are not resolved in our favor, our     <font color="blue">operations</font> may be <font color="blue">negatively</font> impacted and we may be subject to <font color="blue">significant</font>     fines</td>
    </tr>
    <tr>
      <td>Although we believe that the class action suits against <font color="blue">management</font> that     surfaced  as a result of the <font color="blue">billing allegations at</font> the <font color="blue">West Hempstead     </font>patient-care center are <font color="blue">without merit</font>, if the <font color="blue">courts decide</font> in favor of the     plaintiffs, we may be subject to monetary and/or compensatory damages</td>
    </tr>
    <tr>
      <td>In     addition,  if  the  results of the <font color="blue">investigation at</font> the <font color="blue">West Hempstead     </font>patient-care center and any other patient-care centers uncover billing     <font color="blue">discrepancies</font>,  we  may be responsible for <font color="blue">noncompliance fines</font> and the     extension of <font color="blue">such investigation</font> to other patient-care centers</td>
    </tr>
    <tr>
      <td>We may be unable to <font color="blue"><font color="blue">successfully</font> integrate</font> and operate other O&amp;P <font color="blue">businesses</font>     that we acquire in the future</td>
    </tr>
    <tr>
      <td>Part of our business strategy involves the <font color="blue">acquisition</font> and <font color="blue">integration</font> of     small and medium-sized O&amp;P <font color="blue">businesses</font></td>
    </tr>
    <tr>
      <td>We may not be able to <font color="blue">successfully</font>     consummate and/or integrate future <font color="blue">acquisition</font>s</td>
    </tr>
    <tr>
      <td>We <font color="blue">continuously review</font>     <font color="blue">acquisition</font>  prospects  that <font color="blue">would complement</font> our existing <font color="blue">operations</font>,     increase our size and allow us to expand into under-served geographic areas     or  otherwise  offer  growth  <font color="blue">opportunities</font></td>
    </tr>
    <tr>
      <td>The  financing for these     <font color="blue">acquisition</font>s  could <font color="blue">significant</font>ly dilute our investors or result in an     increase  in  our  <font color="blue">indebtedness</font></td>
    </tr>
    <tr>
      <td>We may acquire or make investments in     <font color="blue">businesses</font> or products in the future</td>
    </tr>
    <tr>
      <td><font color="blue">Acquisitions </font><font color="blue">may entail numerous</font>     <font color="blue">integration</font> risks and <font color="blue">impose costs on us</font>, including:         • <font color="blue">difficulties</font> in <font color="blue">assimilating</font> acquired <font color="blue">operations</font> or products, including     the loss of <font color="blue">key employees from</font> acquired <font color="blue">businesses</font>;         • diversion of <font color="blue">management</font>’s attention from our core business concerns;         • <font color="blue">adverse effects on existing</font> business <font color="blue">relationships</font> with suppliers and     customers;         • risks of <font color="blue">entering markets</font> in which we have no or limited experience;         • <font color="blue">dilutive issuances</font> of <font color="blue">equity securities</font>;         • incurrence of substantial debt;         • <font color="blue">assumption</font> of <font color="blue">contingent liabilities</font>; and                                         22       _________________________________________________________________         • incurrence of <font color="blue">significant</font> immediate write-offs</td>
    </tr>
    <tr>
      <td>Our failure to <font color="blue">successfully</font> complete the <font color="blue">integration</font> of future <font color="blue">acquisition</font>s     could have a material adverse effect on our results of <font color="blue">operations</font>, business     and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>We make <font color="blue">available free</font> of charge, on     or through our website, our <font color="blue">Annual Report </font>on Form 10-K, <font color="blue">Quarterly Reports </font>on     Form 10-Q, <font color="blue">Current Reports </font>on Form 8-K, and Section 16 filings (ie <font color="blue">Forms     </font>3, 4 and 5) as soon as reasonably practicable after <font color="blue">electronically filing</font>     such   reports   with   the  <font color="blue">Securities  </font>and  Exchange  Commission  at     http://www</td>
    </tr>
    <tr>
      <td>Our <font color="blue">website also contains</font> the charters of the Audit     Committee, Corporate Governance and Nominating Committee, Compensation     Committee and Quality and Technology Committee of our board of <font color="blue">directors</font>;     our Code of Business Conduct and Ethics for Directors and Employees, which     includes our principal executive, financial and <font color="blue">accounting</font> officers; as well     as our <font color="blue">Corporate Governance Guidelines</font></td>
    </tr>
    <tr>
      <td><font color="blue">Information </font><font color="blue">contained on</font> our website     is not part of this report</td>
    </tr>
  </tbody>
</table>